Navigation Links
NanoBio in Medical News

MedThink Communications Retained by NanoBio Corporation

RALEIGH, N.C., Sept. 4 /PRNewswire/ -- MedThink Communications, an innovator in health care communications and public relations, has been retained by NanoBio Corporation to promote its novel technology that uses nano-sized particles to eradicate skin infections, without harming normal tissue. ...

Excaliard Pharmaceuticals Appoints Jay Birnbaum, Ph.D. to the Board of Directors.

... Society of Dermatology. He is a member of the board of directors of Oculus Innovative Sciences, Inc. and is on the Science Advisory Boards of Evolva, nanobio Corp, NexMed, Inc., Topica Pharmaceuticals, and Transport Pharmaceuticals. He received a B.S. degree from Trinity College and a Ph.D in Pharmac...

NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009

... ANN ARBOR, Mich., March 2 /PRNewswire/ -- nanobio Corp. announced today that it will present compell... kiosks provided by the AAD during the conference. nanobio will also sponsor corporate booth # 5284, where in...s With Distal Subungual Onychomycosis About nanobio NanoBio(R) Corp. is a privately held biophar...

New intranasal influenza vaccine triggers robust immunity with significantly less antigen

...rrently approved vaccines, according to a study by nanobio Corporation. The new vaccine used only half the st...James R. Baker, Jr., M.D., founder and chairman of nanobio Corp. "The nanoemulsion adjuvant uniquely interact... protect people in the face of a flu pandemic." nanobio plans to begin a phase 1 clinical study for season...

New topical approach to treating nail fungus circumvents problems with current therapy

...tire nail plate, according to a study conducted by nanobio Corporation. The data represent a unique approa...mains a large unmet medical need, according to the nanobio scientists. Oral systemic medications are plagued ...James R. Baker, Jr., M.D., founder and chairman of nanobio Corp. Studies conducted in vitro demonstrate that ...

Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift

...WASHINGTON, D.C. (October 28, 2008) Scientists at nanobio Corporation have demonstrated for the first time i...acy rates to oral systemic drugs, according to the nanobio scientists. Topical treatments are widely consider...James R. Baker, Jr., M.D., founder and chairman of nanobio Corp. "NB-001 employs a physical mode of action to...

Nanoemulsion-Based Intranasal Influenza Vaccine Adjuvant Triggers Robust Immunity Using Significantly Less Antigen

...the immune system," said James R. Baker, Jr., M.D., founder and chairman of nanobio Corp. "The nanoemulsion adjuvant uniquely interacts with these cells to tri...s for a vaccine that would protect people in the face of a flu pandemic." nanobio plans to begin a phase 1 clinical study for seasonal influenza in the first...

Nanoemulsion vaccines show increasing promise

...he HIV vaccine, we used a single protein. We were able to promote an immune response using either source, says Baker. The technology is licensed to nanobio Corp., an Ann Arbor-based biotech company which Baker founded in 2000 and in which he has a financial interest. Baker is the Ruth Dow Doan Professor o...

UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine

... UCLA's California NanoSystems Institute (CNSI) and the University of Tokyo's Center for nanobio Integration (CNBI) will jointly sponsor an international symposium on nanobiotechnology at UCLA Nov. 12. The CNSI-CNBI Symposium on NanoBiotechnolo...

NanoBio Wins 2007 Michigan Innovation Award

...e all of our human resources to achieve success." nanobio is developing a pipeline of products that uses nan... NB-001 and NB-002 -- are expected in early 2008. nanobio has been awarded four U.S. and international paten...tions are pending for its NanoStat(TM) technology. nanobio holds the exclusive rights to license each of the ...
NanoBio in Medical Technology

Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis

...RBOR, Mich., Jan. 29 /PRNewswire/ -- Scientists at nanobio Corp. and the University of Michigan have demons...the nanoemulsion formulation that has been used by nanobio in recent clinical trials to treat skin infections...James R. Baker, Jr., M.D., founder and chairman of nanobio Corp. "We can nebulize our nanoemulsion so that it...

Topical Treatment for Cold Sores Achieves Efficacy of Oral Drugs; Represents Paradigm Shift in the Treatment of Skin Infections

... WASHINGTON, Oct. 28 /PRNewswire/ -- Scientists at nanobio Corporation have demonstrated for the first time i...acy rates to oral systemic drugs, according to the nanobio scientists. Topical treatments are widely consider...James R. Baker, Jr., M.D., founder and chairman of nanobio Corp. "NB-001 employs a physical mode of action to...

NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy

...ve in human tissue, said James R. Baker, Jr., M.D., founder and chairman of nanobio Corp. Studies conducted in vitro demonstrate that NB-002 has robust antifun...phytes, Epidermophyton floccosum, Microsporum canis and Candida albicans. nanobio scientists credit the topical lotion's safety and robust anti-infective act...

NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis

... ANN ARBOR, Mich., March 20 /PRNewswire/ -- nanobio Corporation announced today that it has seen promi...clearly justify completing the study, according to nanobio scientists. "Allowing adequate time for subjects...d James R Baker Jr., M.D., founder and chairman of nanobio Corporation. The ongoing randomized, double-blin...

NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis

... ANN ARBOR, Mich., March 17 /PRNewswire/ -- nanobio Corporation reported top-level findings today from...id James R. Baker Jr., MD, founder and chairman of nanobio Corporation. "Based on the data, nanobio will move immediately to initiate plans to begin p...

NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones

...te equity management firm. The funding has enabled nanobio to conduct phase 2 clinical trials on its two lead...fety concerns or systemic absorption, according to nanobio scientists. Phase 2a and Phase 2b clinical trial...s. "We're delighted by the considerable progress nanobio has achieved in all dimensions, most notably its e...

NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008

... ANN ARBOR, Mich., Feb. 1 /PRNewswire/ -- nanobio Corporation is presenting safety and efficacy resu... James R. Baker Jr., M.D., founder and chairman of nanobio Corporation. "Our human and animal studies show th...hophyton mentagrophytes and Trichophyton rubrum. nanobio is currently conducting a double-blind, placebo-co...

New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity

...t. The University of Michigan holds the patent and nanobio Corporation, a spin-off from the university, licen... James R. Baker Jr., M.D., founder and Chairman of nanobio Corporation. "The nanoemulsion serves as an adjuva...ost immune response against a specific antigen." nanobio is in various stages of testing its extensive pipe...

New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects

...founder of NanoBio Corporation in Ann Arbor, Mich. nanobio scientists developed the lotion. The phase 1 data...ycosis that is highly efficacious and very safe." nanobio Corporation is a spin-off from the University of M...in early 2008. In addition to its topical agents, nanobio is developing a rich pipeline of needle-free vacci...

NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis

... Phase 2 clinical study of NB-002 was initiated by nanobio in the first quarter of 2007. James R. Baker,...e 2 clinical study is currently being conducted by nanobio to evaluate the efficacy and safety of three-dose ... low efficacy rate ranging from 5% to 12%. About nanobio Corporation NanoBio(R) Corporation (NanoBio as one of the top biotechnology companies of 2008. The editors of FierceBiotech evaluated hundreds of privately held firms based on...

David M. Stout Joins NanoBio Corporation's Board of Directors

ANN ARBOR, Mich., May 29 /PRNewswire/ -- NanoBio(R) Corporation, a biopharmaceutical company focused on developing and commercializing novel products for the prevention and treatment of infectious diseases, today announced the appointment of David M. Stout to its Board of Directors. Mr. Stout ...

Dr. Joyce Sutcliffe Joins the NanoBio Team as Vice President of Research

ANN ARBOR, Mich., Oct. 30 /PRNewswire/ -- NanoBio(R) Corporation, a biopharmaceutical company focused on developing and commercializing novel products for the prevention and treatment of infectious diseases, today announced the addition of Joyce Sutcliffe, Ph.D., as vice president of research....

Nanobiotech Center Wins $2.5 Million, 4-Year Grant

... Triad-Based Center of Innovation To Commercialize NC's nanobio Ideas RESEARCH TRIANGLE PARK, N.C., June 16 /PRNewswire-USNewswire/ -- The North Carolina Biotechnology Center has approved a four-year, $2.5 mil...

NanoBio Corporation Raises $12 Million in Series B Financing

... ANN ARBOR, Mich., Feb. 18 /PRNewswire/ -- nanobio Corp., a biopharmaceutical company developing derm... James R. Baker Jr., M.D., founder and chairman of nanobio Corp. "Based upon the strength of our recent data ...he challenging economic conditions." About nanobio NanoBio(R) Corp. is a privately held biopha...

NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists

... ANN ARBOR, Mich., Nov. 13 /PRNewswire/ -- nanobio Corporation announced today that it will present n...ies. The data support the continued development of nanobio treatments for a wide range of skin and mucosal in...), acne, and a broad platform of mucosal vaccines. nanobio has demonstrated robust efficacy and safety in ran...

NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008

...eutic applications and vaccines ANN ARBOR, Mich., Oct. 21 /PRNewswire/ -- nanobio Corporation announced today that it will present compelling new data in nin...he company's presentation schedule during the conference is detailed below. nanobio will also exhibit at corporate booth #408. Sunday, October 26, 2008 11:...

Nanoemulsion vaccines show increasing promise

...he HIV vaccine, we used a single protein. We were able to promote an immune response using either source, says Baker. The technology is licensed to nanobio Corp., an Ann Arbor-based biotech company which Baker founded in 2000 and in which he has a financial interest. Baker is the Ruth Dow Doan Professor o...

Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks

...d James R. Baker Jr., M.D. founder and chairman of nanobio Corporation. nanobio is a spin-off from the University of Michigan. "...ion-fighting capability the vaccine can provide. nanobio is in various stages of testing its pipeline of na...
Other Tags
(Date:7/13/2014)... MarketsandMarkets recently conducted a study on ... 3D rendering; Layout and Animation; Image Reconstruction]: Global ... which analyzes and studies the major market drivers, ... Eastern Europe, Middle East and Africa, Asia-Pacific and ... landscape of the 3D imaging market, providing an ...
(Date:7/13/2014)... July 13, 2014 The Pearland, Texas location ... in age from four months to 12 years of age ... classes to birthday parties and Summer Camps, is now under ... Gym of Pearland after spending over six years at ... including Gym Director. , Berry has over ten years ...
(Date:7/13/2014)... 13, 2014 Recently, 2014QuinceaneraDresses.com, the ... unveiled its new range of gorgeous Quinceanera ... the demand for elegant Quinceanera outfits is huge. ... items. All the company’s newly released dresses are ... are all elegant and vivid. , It ...
(Date:7/13/2014)... 2014 Fadhits.com is popular among worldwide ... are extremely beautiful. Recently, the company has announced its ... 2014. What’s more, all these outfits are available at ... , Additionally, the supplier is now offering similar discounts ... dresses, it has many other designs for sale, including ...
(Date:7/13/2014)... COPENHAGEN, July 13, 2014 A decreased ability ... cognitive impairment and Alzheimer,s disease, while examinations of ... a protein associated with Alzheimer,s, in the brain, ... reported today at the Alzheimer,s Association International Conference ... of the studies, the decreased ability to identify ...
Breaking Medicine News(10 mins):Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7
(Date:7/11/2014)... exists that cannabinoid receptor type 1 can ... influx, and reduce neurotransmitter release. However, some ... can increase extracellular Ca2+ influx and increase ... team, Tongji Hospital Affiliated to Tongji Medical ... China used whole cell voltage-clamp and calcium ...
(Date:7/11/2014)... brains of all vertebrates, information is transmitted through ... chemical signal to be passed from one brain ... most abundant type of synapse, can be either ... learning, memory, perception and cognition, and the balance ... function. For instance, every time we learn ...
(Date:7/10/2014)... June 27, 2014  Pomerantz LLP has filed ... ("Provectus" or the "Company")(NYSE-MKT: PVCT) and certain of ... States District Court, Middle District of ... of a class consisting of all persons or ... between December 17, 2013 and May 22, 2014, ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
Other Contents